Additionally, although some drugs, such as AZ1 [15], have been demonstrated to suppress the advancement of cancers under the mediation of USP28, clinical trials and investigations concerning targeting USP28 for cancer therapy are still insufficient. The gene discussed is USP28; the disease is cancer.